A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia

por Uy, G L, Rettig, M P, Stone, R M, Konopleva, M Y, Andreeff, M, McFarland, K, Shannon, W, Fletcher, T R, Reineck, T, Eades, W, Stockerl-Goldstein, K, Abboud, C N, Jacoby, M A, Westervelt, P, DiPersio, J F
Publicado 2017